Colchicine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis
Conditions:   Post-COVID-19 Syndrome;   Lung Fibrosis Interventions:   Drug: Corticosteroids alone;   Drug: Corticosteroids + Colchicine;   Drug: Corticosteroids + Pirfenidone;   Drug: Corticosteroids + Colchicine + Pirfenidone for ≥ 14 days Sponsor:   Mansoura University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2022 Category: Research Source Type: clinical trials

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
Conditions:   HFpEF - Heart Failure With Preserved Ejection Fraction;   Colchicine Intervention:   Drug: Colchicine Sponsor:   I.M. Sechenov First Moscow State Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2022 Category: Research Source Type: clinical trials